Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.78 USD | -1.33% | -5.24% | -18.53% |
06:31pm | Bristol-Myers Squibb Unveils Positive Data for KarXT in Schizophrenia Treatment | MT |
May. 22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.50% | 85.83B | |
+39.85% | 723B | |
+34.28% | 595B | |
-3.97% | 369B | |
+20.47% | 332B | |
+2.99% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.02% | 168B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Leerink Partners Cuts Price Target on Bristol-Myers Squibb to $47 From $51